NDC 51407-949 – Buprenorphine hydrochloride and naloxone hydrochloride dihydrate

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC51407-949

Product details

Brand name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Generic name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Labeler
Golden State Medical Supply, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
June 27, 2014
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
51407-949-3030 TABLET in 1 BOTTLE (51407-949-30)Apr 13, 2026

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products